Jeremy VisserOct 14, 20231 minEADV 2023 Day 3 Evening: Abrocitinib for Prurigo Nodularis in Chronic PruritisDr. Fiona Lovegrove reports on a late breaking presentation about the efficacy and safety of abrocitinib at the 2023 EADV Congress in Berlin
Jeremy VisserOct 14, 20231 minEADV 2023 Day 3 Afternoon: Efficacy and Safety of RezpegaldesleukinDr. Fiona Lovegrove reports on the late breaking presentation on rezpegaldesleukin at the 2023 EADV Congress in Berlin.
Jeremy VisserOct 14, 20231 minEADV 2023 Day 3 Morning: Bullous DiseasesDr. Fiona Lovegrove reports on bullous diseases at the 2023 EADV Congress in Berlin.
Jeremy VisserOct 13, 20231 minEADV 2023 Day 2 Evening: Molecular Signature of Chronic Hand EczemaDr. Vimal Prajapati reports on common molecular signatures of chronic hand eczema at the 2023 EADV Congress in Berlin.